PURPOSE: To compare the accuracy of liver fat quantification using a three-echo chemical shift-encoded magnetic resonance imaging (MRI) technique without and with correction for confounders with spectroscopy (MRS) as the reference standard. MATERIALS AND METHODS: Fifty patients (23 women, mean age 56.6 ± 13.2 years) with fatty liver disease were enrolled. Patients underwent T2-corrected single-voxel MRS and a three-echo chemical shift-encoded gradient echo (GRE) sequence at 3.0T. MRI fat fraction (FF) was calculated without and with T2* and T1 correction and multispectral modeling of fat and compared with MRS-FF using linear regression. RESULTS: The spectroscopic range of liver fat was 0.11%-38.7%. Excellent correlation between MRS-FF and MRI-FF was observed when using T2* correction (R(2) = 0.96). With use of T2* correction alone, the slope was significantly different from 1 (1.16 ± 0.03, P < 0.001) and the intercept was different from 0 (1.14% ± 0.50%, P < 0.023). This slope was significantly different than 1.0 when no T1 correction was used (P = 0.001). When T2*, T1, and spectral complexity of fat were addressed, the results showed equivalence between fat quantification using MRI and MRS (slope: 1.02 ± 0.03, P = 0.528; intercept: 0.26% ± 0.46%, P = 0.572). CONCLUSION: Complex three-echo chemical shift-encoded MRI is equivalent to MRS for quantifying liver fat, but only with correction for T2* decay and T1 recovery and use of spectral modeling of fat. This is necessary because T2* decay, T1 recovery, and multispectral complexity of fat are processes which may otherwise bias the measurements.
PURPOSE: To compare the accuracy of liver fat quantification using a three-echo chemical shift-encoded magnetic resonance imaging (MRI) technique without and with correction for confounders with spectroscopy (MRS) as the reference standard. MATERIALS AND METHODS: Fifty patients (23 women, mean age 56.6 ± 13.2 years) with fatty liver disease were enrolled. Patients underwent T2-corrected single-voxel MRS and a three-echo chemical shift-encoded gradient echo (GRE) sequence at 3.0T. MRI fat fraction (FF) was calculated without and with T2* and T1 correction and multispectral modeling of fat and compared with MRS-FF using linear regression. RESULTS: The spectroscopic range of liver fat was 0.11%-38.7%. Excellent correlation between MRS-FF and MRI-FF was observed when using T2* correction (R(2) = 0.96). With use of T2* correction alone, the slope was significantly different from 1 (1.16 ± 0.03, P < 0.001) and the intercept was different from 0 (1.14% ± 0.50%, P < 0.023). This slope was significantly different than 1.0 when no T1 correction was used (P = 0.001). When T2*, T1, and spectral complexity of fat were addressed, the results showed equivalence between fat quantification using MRI and MRS (slope: 1.02 ± 0.03, P = 0.528; intercept: 0.26% ± 0.46%, P = 0.572). CONCLUSION: Complex three-echo chemical shift-encoded MRI is equivalent to MRS for quantifying liver fat, but only with correction for T2* decay and T1 recovery and use of spectral modeling of fat. This is necessary because T2* decay, T1 recovery, and multispectral complexity of fat are processes which may otherwise bias the measurements.
Authors: Lidia S Szczepaniak; Pamela Nurenberg; David Leonard; Jeffrey D Browning; Jason S Reingold; Scott Grundy; Helen H Hobbs; Robert L Dobbins Journal: Am J Physiol Endocrinol Metab Date: 2004-08-31 Impact factor: 4.310
Authors: Gavin Hamilton; Takeshi Yokoo; Mark Bydder; Irene Cruite; Michael E Schroeder; Claude B Sirlin; Michael S Middleton Journal: NMR Biomed Date: 2010-12-12 Impact factor: 4.044
Authors: R Longo; P Pollesello; C Ricci; F Masutti; B J Kvam; L Bercich; L S Crocè; P Grigolato; S Paoletti; B de Bernard Journal: J Magn Reson Imaging Date: 1995 May-Jun Impact factor: 4.813
Authors: D K George; S Goldwurm; G A MacDonald; L L Cowley; N I Walker; P J Ward; E C Jazwinska; L W Powell Journal: Gastroenterology Date: 1998-02 Impact factor: 22.682
Authors: Cheng William Hong; Gavin Hamilton; Catherine Hooker; Charlie C Park; Calvin Andrew Tran; Walter C Henderson; Jonathan C Hooker; Soudabeh Fazeli Dehkordy; Jeffrey B Schwimmer; Scott B Reeder; Claude B Sirlin Journal: Abdom Radiol (NY) Date: 2019-10
Authors: Dennis M Hedderich; Till Hasenberg; Stefan Haneder; Stefan O Schoenberg; Özlem Kücükoglu; Ali Canbay; Mirko Otto Journal: Obes Surg Date: 2017-07 Impact factor: 4.129
Authors: Cheng William Hong; Soudabeh Fazeli Dehkordy; Jonathan C Hooker; Gavin Hamilton; Claude B Sirlin Journal: Top Magn Reson Imaging Date: 2017-12
Authors: Utaroh Motosugi; Diego Hernando; Peter Bannas; James H Holmes; Kang Wang; Ann Shimakawa; Yuji Iwadate; Valentina Taviani; Jennifer L Rehm; Scott B Reeder Journal: J Magn Reson Imaging Date: 2015-04-01 Impact factor: 4.813
Authors: Cheng William Hong; Tanya Wolfson; Ethan Z Sy; Alexandra N Schlein; Jonathan C Hooker; Soudabeh Fazeli Dehkordy; Gavin Hamilton; Scott B Reeder; Rohit Loomba; Claude B Sirlin Journal: J Magn Reson Imaging Date: 2017-08-26 Impact factor: 4.813
Authors: Cheng William Hong; Adrija Mamidipalli; Jonathan C Hooker; Gavin Hamilton; Tanya Wolfson; Dennis H Chen; Soudabeh Fazeli Dehkordy; Michael S Middleton; Scott B Reeder; Rohit Loomba; Claude B Sirlin Journal: J Magn Reson Imaging Date: 2017-08-29 Impact factor: 4.813